Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of depression as part of end-of-life care.

Literature DB >> 21720540

Treatment of depression as part of end-of-life care.

Breffni Hannon¹, Peter Fitzgerald, Marie Murphy.

Abstract

We present a case report of a severe treatment resistant major depressive episode in a patient with advanced cancer and limited life expectancy which resolved completely within 10 days of commencing combination therapy involving mirtazepine and paroxetine. Aggressive treatment of clinical depression even in the context of short life expectancy (that is, a short number of weeks) can dramatically reduce patient and family distress and improve quality of life.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2008 PMID： 21720540 PMCID： PMC3125543 DOI： 10.1136/bcr.08.2008.0841

Source DB: PubMed Journal: BMJ Case Rep ISSN： 1757-790X

Keyword Cloud
References

10 in total

Review 1. Mirtazepine: heir apparent to amitriptyline?

Authors: M P Davis; E D Dickerson; M Pappagallo; C Benedetti; P A Grauer; J Lycan
Journal: Am J Hosp Palliat Care Date: 2001 Jan-Feb Impact factor: 2.500

2. "Are you depressed?" Screening for depression in the terminally ill.

Authors: H M Chochinov; K G Wilson; M Enns; S Lander
Journal: Am J Psychiatry Date: 1997-05 Impact factor: 18.112

3. Psychiatric aspects of excellent end-of-life care. Ad Hoc Committee on End-of-Life Care. The Academy of Psychosomatic Medicine.

Authors: J L Shuster; W Breitbart; H M Chochinov
Journal: Psychosomatics Date: 1999 Jan-Feb Impact factor: 2.386

Treatment of depression as part of end-of-life care.

Review 1. Mirtazepine: heir apparent to amitriptyline?

2. "Are you depressed?" Screening for depression in the terminally ill.

3. Psychiatric aspects of excellent end-of-life care. Ad Hoc Committee on End-of-Life Care. The Academy of Psychosomatic Medicine.

Review 4. Mirtazapine: clinical advantages in the treatment of depression.

Review 5. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.

Review 6. Depression in advanced disease: a systematic review Part 1. Prevalence and case finding.

Review 7. Which depression screening tools should be used in palliative care?

8. How do palliative medicine physicians assess and manage depression.

9. Sensitivity and specificity of a two-question screening tool for depression in a specialist palliative care unit.

Review 10. The pharmacologic profile of mirtazapine.